A generalizable method for the purification and biophysical characterization of bacterial membrane receptors
Protein Science · 2026-11 · 35 (11)
DOI: 10.1002/pro.70825 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein Science, online erschienen am 15.10.2026. Verfasst von Federico Bosetto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Bacterial Proteins, Pseudomonas aeruginosa, Membrane Proteins, Receptors, Cell Surface. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Society, Ernest Oppenheimer Fund, Human Frontier Science Program.
Abstract (Originalsprache)
Membrane‐embedded bacterial receptors are challenging to express and purify in soluble form, yet their isolated domains are essential tools for structural and ligand‐discovery studies. Pseudomonas aeruginosa relies on the TonB‐dependent heme receptor HasR for iron acquisition, a process central to its pathogenicity. Here, we report a robust strategy for the recombinant expression, purification, and biophysical characterization of the two soluble HasR domains directly involved in heme uptake: the N‐terminal plug and the Secretin/TonB short N‐terminal domain. Each domain was expressed individually in Escherichia coli and purified to homogeneity, adopting well‐folded conformations as confirmed by circular dichroism, NMR spectroscopy, and mass spectrometry. We then engineered a fusion construct containing both domains and systematically evaluated multiple solubilization tags. A GST‐His dual‐affinity strategy enabled efficient purification of the construct, whereas His6‐tag alone resulted in insoluble protein and HLT‐tag fusions suffered from non‐specific proteolysis. Biophysical analyses revealed that the Secretin/TonB short N‐terminal domain remains stably folded within the fusion construct, while the N‐terminal plug domain becomes partially disordered, a finding further supported by hydrogen/deuterium exchange mass spectrometry. Together, these results establish a generalizable workflow for producing soluble receptor domains from membrane proteins and provide validated HasR constructs suitable for downstream ligand‐screening applications, including aptamer and nanobody discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University of Cambridge, Cambridge, UK.
- Living Systems Institute, University of Exeter, Exeter, UK.
- Department of Biosciences, University of Exeter, Exeter, UK.
- Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.
ORCID-Profile: Federico Bosetto, Maria Zacharopoulou, Giovanna Zinzalla, Stephen H McLaughlin, Ioanna Mela
Förderung
- Royal Society
- Ernest Oppenheimer Fund
- Human Frontier Science Program
- UK Research and Innovation
- Cancer Research UK
- Medical Research Council
- Wellcome Trust
- David James Trust
Zitieren
APA
Bosetto, F., Zacharopoulou, M., Bycroft, M., Kish, M., Zinzalla, G., Rowling, P. J. E., McLaughlin, S. H., Phillips, J. J., Itzhaki, L. S., & Mela, I. (2026). A generalizable method for the purification and biophysical characterization of bacterial membrane receptors. Protein Science, 35(11). https://doi.org/10.1002/pro.70825
Vancouver
Bosetto F, Zacharopoulou M, Bycroft M, Kish M, Zinzalla G, Rowling PJE, et al. A generalizable method for the purification and biophysical characterization of bacterial membrane receptors. Protein Science. 2026;35(11). doi:10.1002/pro.70825
BibTeX
@article{Bosetto2026,
author = {Bosetto, Federico and Zacharopoulou, Maria and Bycroft, Mark and Kish, Monika and Zinzalla, Giovanna and Rowling, Pamela J E and McLaughlin, Stephen H and Phillips, Jonathan J and Itzhaki, Laura S and Mela, Ioanna},
title = {A generalizable method for the purification and biophysical characterization of bacterial membrane receptors},
journal = {Protein Science},
year = {2026},
volume = {35},
number = {11},
doi = {10.1002/pro.70825}
}
EUVIMED